KP-MRT-RYHomo sapiens (Human)Cancer cell line

Also known as: Kyoto Pediatrics-Malignant Rhabdoid Tumor-RY, KPMRTRY

AI Summary

No AI-generated summary available for this cell line.

Basic Information

Database IDCVCL_7051
SpeciesHomo sapiens (Human)
Tissue SourceKidney[UBERON:UBERON_0002113]

Donor Information

0
Age CategoryPediatric
SexMale

Disease Information

DiseaseRhabdoid tumor
LineageKidney
SubtypeRhabdoid Cancer
OncoTree CodeMRT

DepMap Information

Source TypeAcademic lab
Source IDACH-001109_source
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Next-generation characterization of the Cancer Cell Line Encyclopedia.

Sellers W.R.

Nature 569:503-508(2019).

Sensitivity of malignant rhabdoid tumor cell lines to PD 0332991 is inversely correlated with p16 expression.

Sugimoto T., Houghton P.J., Hosoi H.

Biochem. Biophys. Res. Commun. 413:62-68(2011).

Trastuzumab activates allogeneic or autologous antibody-dependent cellular cytotoxicity against malignant rhabdoid tumor cells and interleukin-2 augments the cytotoxicity.

Iehara T., Kuroda H., Hosoi H., Sugimoto T.

Clin. Cancer Res. 14:1192-1199(2008).